89BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.7 USD | -0.11% |
|
-9.28% | -22.11% |
| 10/05 | HC Wainwright Adjusts 89bio's Price Target to $29 From $31, Maintains Buy Rating | MT |
| 09/05 | 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 89BIO, INC. | Bio Therapeutic Drugs | -0.11% | -9.28% | -22.11% | -51.40% | - | 856M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ETNB Stock
- Charts 89bio, Inc.
- Comparison Chart